These limitations from the BTNX NTS are hugely pertinent, as we identified e.g. etodesnitazene to own the same in vitro potency and efficacy as fentanyl [seven, 13] and as it might most likely give PWUD a false perception of protection. Additionally, the detectability of nitazene analogues in drug samples could be impacted by solubility problems, a